Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoki Kashihara

Showing results (161-170 of 206) with videos related to

Pageof 21
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 9, 2025
The Nonsteroidal Mineralocorticoid Receptor Blocker Esaxerenone reduces glomerular hyperfiltration and albuminuriaRie Tatsugawa, Kengo Kidokoro, Tsukasa Iwakura Akira Hirano, et al.
Clinical and Experimental Nephrology|April 20, 2024
Effects of empagliflozin in patients with chronic kidney disease from Japan: exploratory analyses from EMPA-KIDNEYMasaomi Nangaku, William G Herrington, Shinya Goto, et al.
Clinical and Experimental Nephrology|July 26, 2017
A nationwide prospective cohort study of patients with advanced chronic kidney disease in Japan: The Reach-J CKD cohort studyJunichi Hoshino, Kei Nagai, Hirayasu Kai, et al.
Clinical and Experimental Nephrology|June 3, 2022
Chronic kidney disease and clinical outcomes in patients with COVID-19 in JapanRyosuke Sato, Yasushi Matsuzawa, Hisao Ogawa, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 10, 2025
Maintaining kidney health in aging societies: a JSN and ERA call to actionAlberto Ortiz, Anneke Kramer, Ivan Rychlík, et al.
American Journal of Nephrology|July 10, 2026
Kidney and Cardiovascular Outcomes by CKD stage and etiology of CKD: A Randomly Selected Nationwide Prospective Multicenter Cohort Study in Japan (Reach-J Study)Ryoya Tsunoda, Tomohiro Ohigashi, Junichi Hoshino, et al.
Journal of the American Society of Nephrology : JASN|August 17, 2022
Correlates and Consequences of an Acute Change in eGFR in Response to the SGLT2 Inhibitor Dapagliflozin in Patients with CKDNiels Jongs, Glenn M Chertow, Tom Greene, et al.
Journal of Human Genetics|November 20, 2022
Genome-wide association study of the risk of chronic kidney disease and kidney-related traits in the Japanese population: J-Kidney-BiobankYuka Sugawara, Yosuke Hirakawa, Hajime Nagasu, et al.
Clinical and Experimental Nephrology|April 21, 2021
Comparison of annual eGFR decline among primary kidney diseases in patients with CKD G3b-5: results from a REACH-J CKD cohort studyJunichi Hoshino, Ryoya Tsunoda, Kei Nagai, et al.
BMJ Open Diabetes Research & Care|March 25, 2020
Conditions, pathogenesis, and progression of diabetic kidney disease and early decliner in JapanYui Yoshida, Kosuke Kashiwabara, Yosuke Hirakawa, et al.
Pageof 21

Showing results (161-170 of 206) with videos related to

Sort By:
Pageof 21
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 9, 2025
The Nonsteroidal Mineralocorticoid Receptor Blocker Esaxerenone reduces glomerular hyperfiltration and albuminuriaRie Tatsugawa, Kengo Kidokoro, Tsukasa Iwakura Akira Hirano, et al.
Clinical and Experimental Nephrology|April 20, 2024
Effects of empagliflozin in patients with chronic kidney disease from Japan: exploratory analyses from EMPA-KIDNEYMasaomi Nangaku, William G Herrington, Shinya Goto, et al.
Clinical and Experimental Nephrology|July 26, 2017
A nationwide prospective cohort study of patients with advanced chronic kidney disease in Japan: The Reach-J CKD cohort studyJunichi Hoshino, Kei Nagai, Hirayasu Kai, et al.
Clinical and Experimental Nephrology|June 3, 2022
Chronic kidney disease and clinical outcomes in patients with COVID-19 in JapanRyosuke Sato, Yasushi Matsuzawa, Hisao Ogawa, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 10, 2025
Maintaining kidney health in aging societies: a JSN and ERA call to actionAlberto Ortiz, Anneke Kramer, Ivan Rychlík, et al.
American Journal of Nephrology|July 10, 2026
Kidney and Cardiovascular Outcomes by CKD stage and etiology of CKD: A Randomly Selected Nationwide Prospective Multicenter Cohort Study in Japan (Reach-J Study)Ryoya Tsunoda, Tomohiro Ohigashi, Junichi Hoshino, et al.
Journal of the American Society of Nephrology : JASN|August 17, 2022
Correlates and Consequences of an Acute Change in eGFR in Response to the SGLT2 Inhibitor Dapagliflozin in Patients with CKDNiels Jongs, Glenn M Chertow, Tom Greene, et al.
Journal of Human Genetics|November 20, 2022
Genome-wide association study of the risk of chronic kidney disease and kidney-related traits in the Japanese population: J-Kidney-BiobankYuka Sugawara, Yosuke Hirakawa, Hajime Nagasu, et al.
Clinical and Experimental Nephrology|April 21, 2021
Comparison of annual eGFR decline among primary kidney diseases in patients with CKD G3b-5: results from a REACH-J CKD cohort studyJunichi Hoshino, Ryoya Tsunoda, Kei Nagai, et al.
BMJ Open Diabetes Research & Care|March 25, 2020
Conditions, pathogenesis, and progression of diabetic kidney disease and early decliner in JapanYui Yoshida, Kosuke Kashiwabara, Yosuke Hirakawa, et al.
Pageof 21